Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    7114936 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Study of Continuous Dosing of Sunitinib in Non GIST Sarcomas With Concomitant Radiotherapy
Condition: Non GIST Sarcomas
Intervention: Drug: sunitinib
2 Withdrawn Proton Chemoradiotherapy for High-Risk Soft Tissue Sarcomas
Condition: Soft Tissue Sarcomas
Interventions: Drug: Chemoradiotherapy Temozolomide;   Radiation: Proton therapy;   Procedure: Proton Chemoradiotherapy followed by surgery

Indicates status has not been verified in more than two years